FindTrial
Sign In

Usefullness of new rapid tool called Cartridge Based Nucelic Acid Amplification Test for diagnosis of tuberculosis in urban tumakuru

Utilization of cartridge based nucelic acid amplification test for presumptive Tuberculosis diagnosis in urban Tumakuru

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/12/016729
Enrollment
52
Registered
2018-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Sphoorthi Narasimhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CB NAAT operating Technician, lab technician, hospital manager, and medical officer

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To assess the utilization of CB NAAT pattern for presumptive diagnosis for drug resistance in tuberculosis in urban TumakuruTimepoint: last week of april—

Secondary

MeasureTime frame
To assess the utilization of CB NAAT pattern for presumptive diagnosis for drug resistance in tuberculosis in urban TumakuruTimepoint: last week of april—

Countries

India

Contacts

Public ContactDr Sanath Kumar G K

Prasanna School of Public Health, MAHE, Manipal

arathi.anil@manipal.edu9008418848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026